Literature DB >> 20133008

Large cell/neuroendocrine carcinoma.

Russell Gollard1, Sejal Jhatakia, Max Elliott, Michael Kosty.   

Abstract

Large cell neuroendocrine tumors of the lung represent a recently reclassified subtype of lung cancer with features of both small cell and non-small cell lung cancer. We review diagnostic difficulties, typical presentations, and the natural history of this tumor. We review treatment data, and suggest that as in more common types of lung cancer, multi-modality therapy may be the most promising course of treatment. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20133008     DOI： 10.1016/j.lungcan.2009.12.011

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


  13 in total

1.  Leptomeningeal metastasis of pulmonary large-cell neuroendocrine carcinoma: A case report and review of the literature.

Authors:  Guozi Yang; Zhenyu Pan; Ning Ma; Limei Qu; Tingting Yuan; Xiaochuan Pang; Xu Yang; Lihua Dong; Shixin Liu
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

Review 2.  [Non-small cell lung cancer. New biomarkers for diagnostics and therapy].

Authors:  G Kayser
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

Review 3.  Neuroendocrine carcinoma of the extrahepatic bile duct: case report and literature review.

Authors:  Eizaburo Sasatomi; Michael A Nalesnik; J Wallis Marsh
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

4.  Outcomes of Curative-Intent Surgery and Adjuvant Treatment for Pulmonary Large Cell Neuroendocrine Carcinoma.

Authors:  Kun Woo Kim; Hong Kwan Kim; Jhingook Kim; Young Mog Shim; Myung-Ju Ahn; Yoon-La Choi
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

5.  Simultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samples.

Authors:  Gian Kayser; Agnes Csanadi; Claudia Otto; Till Plönes; Nicola Bittermann; Justyna Rawluk; Bernward Passlick; Martin Werner
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

6.  Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas.

Authors:  Juliane Rieber; Julian Schmitt; Arne Warth; Thomas Muley; Jutta Kappes; Florian Eichhorn; Hans Hoffmann; Claus Peter Heussel; Thomas Welzel; Jürgen Debus; Michael Thomas; Martin Steins; Stefan Rieken
Journal:  Eur J Med Res       Date:  2015-08-14       Impact factor: 2.175

7.  A retrospective analysis of the clinicopathological characteristics of large cell carcinoma of the lung.

Authors:  Rui Liang; Tian-Xing Chen; Zhi-Qiang Wang; Ke-Wei Jin; Lian-Yu Zhang; Qing-Na Yan; Hui-Hua Zhang; Wan-Pu Wang
Journal:  Exp Ther Med       Date:  2014-11-17       Impact factor: 2.447

8.  Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.

Authors:  Yuki Matsumura; Shigeki Umemura; Genichiro Ishii; Koji Tsuta; Shingo Matsumoto; Keiju Aokage; Tomoyuki Hishida; Junji Yoshida; Yuichiro Ohe; Hiroyuki Suzuki; Atsushi Ochiai; Koichi Goto; Kanji Nagai; Katsuya Tsuchihara
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-20       Impact factor: 4.553

9.  Pulmonary Large Cell Neuroendocrine Carcinoma: A Rare Type of Non-Small Cell Lung Cancer.

Authors:  Thomas G Ng; Hyo-Bin Um; Mark Forsberg; Usha Trivedi; Jason George
Journal:  Cureus       Date:  2021-04-28

10.  Advanced composite of large cell neuroendocrine carcinoma and squamous cell carcinoma: a case report of uterine cervical cancer in a virgin woman.

Authors:  Ryusuke Murakami; Iemasa Kou; Kenjiro Date; Hirofumi Nakayama
Journal:  Case Rep Obstet Gynecol       Date:  2013-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.